Intellia Therapeutics
NTLA
NTLA
140 hedge funds and large institutions have $569M invested in Intellia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
46
Reduced
35
Closed
24
Calls
$1.12M
Puts
$1.67M
Net Calls
-$548K
Net Calls Change
+$567K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$18.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.1M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.26M |
| 4 |
BlackRock
New York
|
+$1.8M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.2M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$3.71M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.7M |
| 3 |
AG
Artal Group
Luxembourg
|
-$2.93M |
| 4 |
Two Sigma Investments
New York
|
-$1.52M |
| 5 |
3C
361 Capital
Denver,
Colorado
|
-$1.39M |
